Companies you'll love to work for

T-Therapeutics Ltd
T-Therapeutics Ltd
t-therapeutics.com

Locations

Cambridge, UK · Streetly End, Cambridge CB21 4RP, UK

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series A

founded in

2022

T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge, focused on harnessing T cell biology to create safe and effective treatments for cancer and autoimmune diseases. Utilizing their proprietary Op Ti Mus® platform, they develop optimal TCR-based therapeutics that target multiple classes of cancer, aiming to reshape the clinical landscape with first-in-class drugs. The company combines expertise in mouse genome engineering, biopharmaceutical drug development, single cell genomics, machine-learning, and structural biology, fostering a culture of creativity and collaboration to drive innovation in T cell receptor-based medicines.

Something looks off?
Open jobs at T-Therapeutics Ltd

On-site & Remote